Pharmaceutical products: Corglycon solution for injection, 0.6 mg/ml, 1 ml; Caffeine sodium benzoate, solution for injection, 100 mg/ml, 1 ml each; Chloropyramine, solution for injection, 20 mg/ml, 1 ml each; Prednisone, solution for injection, 30 mg/ml, 1 ml each; Platyphylline solution forinjection, 2 mg/ml, 1 ml each; Metamizole sodium, solution for injection, 500 mg/ml, 2 ml; Captopril/hydrochlorothiazide, tablets, 50/12.5 mg each; Sodium chloride, solution for injection, 9 mg/ml, 5 ml each;
By: Valentina Mykolaivna Chepur๐ UkraineClosed
Key Information
| Reference | GB-UA-2026-11-02-006399-a |
|---|
| Deadline | Nov 9, 2026 12:00 AM |
|---|
| Estimated Value | UAH 4,037,420.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 20603, Ukraine, Cherkasy region, Shpola, SOBORNA STREET, building 58 |
|---|
| Published | Nov 2, 2026 |
|---|
Description
Pharmaceutical products: Corglycon solution for injection, 0.6 mg/ml, 1 ml; Caffeine sodium benzoate, solution for injection, 100 mg/ml, 1 ml each; Chloropyramine, solution for injection, 20 mg/ml, 1 ...
Full details are available after unlocking this tender.